A recent study found that older adults with diabetes who use a GLP-1 drug have double the risk of developing wet age-related ...

Market is one of the leading causes of irreversible vision loss in individuals aged 50 and above. With the global aging population increasing rapidly, the burden of AMD is escalating, pushing the ...

Instant coffee has been linked to macular degeneration, which has no cure and progressively causes vision issues ...

Optical coherence tomography markers—like the ellipsoid zone—are reshaping clinical trials in intermediate age-related ...

New research suggests a link between some weight loss drugs and potentially blinding eye diseases. That risk is especially high for older adults. A recent study found that older adults with diabetes ...

The market is projected to grow at a compound annual growth rate (CAGR) of approximately 6.4% from 2025 to 2035, increasing from USD 18466.9 Million in 2025 to USD 34340.7 Million by 2035.

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

Receiving the SMC recommendation of LYTENAVA™ (bevacizumab gamma) for patients with wet AMD is a significant milestone for our company and a testament to our commitment to improving patient outcomes,” ...

Jay Chhablani, MD, explains how 3D choroidal vessel segmentation transforms ophthalmology, enhancing disease diagnosis and treatment through advanced imaging technology.